DePuy Mitek BIOKNOTLESS Rapid W/ OC-Indicated for use in soft tissue to bone fixation in associat...

FDA Device Recall #Z-1680-2023 — Class II — April 13, 2023

Recall Summary

Recall Number Z-1680-2023
Classification Class II — Moderate risk
Date Initiated April 13, 2023
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm DePuy Mitek, Inc., a Johnson & Johnson Co.
Location Norwood, MA
Product Type Devices
Quantity 3328 units

Product Description

DePuy Mitek BIOKNOTLESS Rapid W/ OC-Indicated for use in soft tissue to bone fixation in association with adequate postoperative immobilization Model Number: 212722

Reason for Recall

IFU Warning: Applying bending force and/or bending force with impaction to the BIOKNOTLESS¿ Anchor Inserter may cause a fragment of the inserter tip to break off during use and be retained in the patient. broken BIOKNOTLESS¿ Anchor inserter tip detected during surgery may require removal, potentially causing bone damage and longer surgery time

Distribution Pattern

Worldwide distribution - US Nationwide and the countries of Australia, Belgium, Canada, Switzerland, China, Czech Republic, Germany, Egypt, Spain, United Kingdom, Hong Kong, Hungary, Ireland, India, Italy, Korea, Netherlands, New Zealand, Slovakia, Thailand.

Lot / Code Information

UDI-DI: 10886705002085 All lot numbers

Other Recalls from DePuy Mitek, Inc., a Johnson & Johnso...

Recall # Classification Product Date
Z-1314-2025 Class II COR Disposable Kit, 8 mm. Cartilage Transplant ... Feb 24, 2025
Z-1315-2025 Class II COR Disposable Kit, 8 mm w/ Perpendicularity. C... Feb 24, 2025
Z-1678-2023 Class II DePuy Mitek BIOKNOTLESS Plus w/ Panacryl-Indica... Apr 13, 2023
Z-1679-2023 Class II DePuy Mitek BIOKNOTLESS Plus w/ OC-Indicated fo... Apr 13, 2023
Z-1677-2023 Class II DePuy Mitek BIOKNOTLESS Plus w/ Ethibond-Iindic... Apr 13, 2023

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.